Consumer genomics platform offering actionable health insights and pharmacogenomics
VitaGenomics offers a DTC genomics platform with clinical-grade pharmacogenomic reports. Their proprietary ML pipeline analyzes whole-genome sequencing data to predict drug responses, disease predispositions, and optimal wellness plans. 280K kits sold with 94% customer satisfaction. B2B channel launched with 15 health systems.
Exceptional founding team with deep domain expertise — CEO is ex-Illumina VP, CSO published 40+ papers in Nature Genetics. Product-market fit is strong with organic growth accelerating. Main risk is regulatory uncertainty around DTC genomic health claims in the EU. Recommend advancing to Pre-DD.
Available at Pre-DD level